SCHEMBL8335857

SCHEMBL8335857

CNC(=S)N(C)C(=O)C(C)c1ccc(OC)c(N=S(=O)=O)c1

nearest known ligand 0.36

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ PTGS2 P35354 1/20 0.30
▸ HIF1A Q16665 2/20 0.30
▸ AKR1C3 P42330 1/20 0.30
▸ AKR1C2 P52895 1/20 0.30
▸ KMT2A Q03164 1/20 0.30
▸ GALR3 O60755 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ NR2F2 P24468 1/20 0.30
▸ RAB9A P51151 1/20 0.30
▸ SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8336542 0.90 PTGS2 (0.32) PTGS2HIF1AAKR1C3AKR1C2
SCHEMBL8334835 0.89 GAA (0.31) GAAALDH1A1PTGS2HIF1AAKR1C3
SCHEMBL8334767 0.86 ALDH1A1 (0.33) GAAALDH1A1HIF1AKMT2ALMNA
SCHEMBL8333752 0.85 HIF1A (0.34) ALDH1A1HIF1ALMNASMN1; SMN2
SCHEMBL8336357 0.85 HIF1A (0.34) ALDH1A1HIF1ALMNASMN1; SMN2
SCHEMBL8334478 0.85 BCHE (0.30) —
SCHEMBL8333474 0.85 NPSR1 (0.33) GAAALDH1A1HIF1ALMNASMN1; SMN2
SCHEMBL8389248 0.84 TAS1R3 (0.32) ALDH1A1HIF1ALMNASMN1; SMN2
SCHEMBL8336116 0.83 SMN1; SMN2 (0.35) GAAALDH1A1HIF1AKMT2ALMNA
SCHEMBL8339599 0.82 TSHR (0.36) GAAALDH1A1HIF1AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5977177-A Substituted benzenesulfonylureas and-thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them HOECHST AKTIENGESELLSCHAFT (DE) 1999-11-02 — — US disclosed
US-5880155-A TREATMENT OF CARDIOVASCULAR DISORDERS HOECHST AKTIENGESELLSCHAFT (DE) 1999-03-09 — — US disclosed
Send feedback